FORA Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

FORA Capital’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,648	Closed	-$1.6M	–	613
2023 Q2	$1.6M	Buy	+41,648	New	+$1.07M	0.23%	122

FORA Capital's KDNY Position: Q3 2023 in Review

FORA Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 41,648 shares — an estimated $1.6M sold.

FORA Capital first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $1.6M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

FORA Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
FORA Capital sold 41,648 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.6M.
FORA Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
FORA Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $1.6M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on FORA Capital's 13F filing for Q3 2023, filed 13 Nov 2023.